ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



In silico molecular docking and ADME/T analysis of plant compounds against IL17A and IL18 targets in gouty arthritis

SOWMYA HARI.



Abstract
Download PDF Cited by 32 ArticlesPost

Accumulation of urate crystals and subsequent inflammation are the major cause of pathogenesis of gout. Two pro inflammatory cytokines IL17A and IL18 are upregulated in the serum of gout patients and plays a major role in promoting inflammation. Inhibition of these cytokines by plant phytochemicals would reduce the severity of inflammation in gout. In the present study, in silico analysis of inhibition of IL17A and IL18 by 10 plant phytochemicals were studied using the AutoDock 4.2 based on the principles of Lamarckian genetic algorithm. The results revealed a binding energy in the range of -6.32 kcal/mol to - 3.5 kcal/mol and interacted with the amino acids in active pocket of IL17A and IL18. Among all the compounds, syringaresinol showing the least binding energy of -6.05 kcal/mol with IL17A and -6.32 kcal/mol with IL18. The control drug, allopurinol showed a binding energy of -3.32 and -3.18 kcal/mol with IL17A and IL18 respectively. In addition, ADME properties of the compounds were also analyzed to predict their drug likeliness. This docking study can be used for developing potent inhibitors of IL17A and IL18 for the treatment of gout.

Key words: Gout, IL17A, IL18, in silico, AutoDock, ADME/T







Bibliomed Article Statistics

28
28
34
31
37
46
37
21
44
47
44
11
R
E
A
D
S

8

17

15

10

12

22

9

14

14

13

12

4
D
O
W
N
L
O
A
D
S
010203040506070809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.